Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia
- PMID: 36229905
- PMCID: PMC9561141
- DOI: 10.3961/jpmph.22.248
Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia
Abstract
Objectives: The Indonesian Ministry of Health launched isoniazid preventive therapy (IPT) in 2016, with general practitioners (GPs) at the frontline of this program. However, the extent to which GPs have internalized this program remains uncertain. The aim of this study was to identify the knowledge and attitudes of GPs towards the IPT program in Indonesia.
Methods: This study used an online, self-administered questionnaire distributed via e-mail and social messaging services. A logistic regression model was employed to identify the explanatory variables influencing the level of knowledge and attitudes toward IPT among GPs in Indonesia. An empirical analysis was conducted separately for each response variable (knowledge and attitudes).
Results: Of the 418 respondents, 128 (30.6%) had a good knowledge of IPT. Working at a public hospital was the only variable associated with good knowledge, with an adjusted odds ratio (aOR) of 1.69 (95% confidence interval [CI], 1.02 to 2.81). Furthermore, 279 respondents (66.7%) had favorable attitudes toward IPT. In the adjusted logistic regression analysis, good knowledge (aOR, 0.55; 95% CI, 0.34 to 0.89), 1-5 years of work experience (aOR, 2.09; 95% CI, 1.21 to 3.60), and having experienced IPT training (aOR, 0.48; 95% CI, 0.25 to 0.93), were significantly associated with favorable attitudes.
Conclusions: In general, GPs in Indonesia had favorable attitudes toward IPT. However, their knowledge of IPT was limited. GPs are an essential element of the IPT program in the country, and therefore, adequate information dissemination to improve their understanding is critical for the long-term viability and quality of the IPT program in Indonesia.
Keywords: General practitioner; Isoniazid; Latent tuberculosis; Tuberculosis.
Conflict of interest statement
The authors have no conflicts of interest associated with the material presented in this paper.
Figures
Similar articles
-
Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.Pan Afr Med J. 2020 Aug 10;36:261. doi: 10.11604/pamj.2020.36.261.22496. eCollection 2020. Pan Afr Med J. 2020. PMID: 33014257 Free PMC article.
-
A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.AIDS Res Ther. 2020 May 27;17(1):28. doi: 10.1186/s12981-020-00285-0. AIDS Res Ther. 2020. PMID: 32460788 Free PMC article.
-
Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).Int J Infect Dis. 2021 Feb;103:562-567. doi: 10.1016/j.ijid.2020.11.192. Epub 2020 Dec 2. Int J Infect Dis. 2021. PMID: 33276111 Free PMC article.
-
[Primary isoniazid preventive therapy : A strategy still relevant in the era of test and treat ; literature review].Rev Epidemiol Sante Publique. 2022 Nov;70(6):305-313. doi: 10.1016/j.respe.2022.09.074. Epub 2022 Oct 25. Rev Epidemiol Sante Publique. 2022. PMID: 36307330 Review. French.
-
Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.BMC Infect Dis. 2014 May 21;14:281. doi: 10.1186/1471-2334-14-281. BMC Infect Dis. 2014. PMID: 24886159 Free PMC article. Review.
References
-
- Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov. 2013;12(5):388–404. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical